MedPath

Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos

Recruiting
Conditions
Artificial Intelligence
Lung Nodule
Registration Number
NCT07098884
Lead Sponsor
Anhui Provincial Hospital
Brief Summary

The current study aims to develop and validate a deep learning signature for diagnosing pathology and predicting prognosis of lung nodule using smartphone photos of resected tumor specimens.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
600
Inclusion Criteria

(1) Participants scheduled for surgery for radiological finding of pulmonary lesions from the preoperative thin-section CT scans; (2) Age ranging from 20-75 years.

Exclusion Criteria

(1) Participants with incomplete clinical information; (2) Participants who have received anti-tumor therapy.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Area under the receiver operating characteristic curveFrom enrollment to the end of the study, assessed up to 6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Anhui Provincial Hospital

🇨🇳

Hefei, Anhui, China

The First Affiliated Hospital of Soochow University

🇨🇳

Suzhou, Jiangsu, China

Ningbo First Hospital

🇨🇳

Ningbo, Zhejiang, China

Anhui Provincial Hospital
🇨🇳Hefei, Anhui, China
Yifan Zhong, PhD
Contact
0551-62283114
yifanzhong@126.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.